$32.52
-0.32-0.97%
Last update: Nov 2, 8:00 PM
iShares Neuroscience and Healthcare ETF (IBRN) Stock Price, Quote, News & History
IBRNARCA
PTC Therapeutics plans to acquire Sangamo’s ST-920 Fabry disease program for $111 million upfront, with FDA filing expected in Q4 2026.
You can purchase shares of iShares Neuroscience and Healthcare ETF (ARCA:IBRN) through any online brokerage.
There are no as such competitors for iShares Neuroscience and Healthcare ETF.
There is no analysis for iShares Neuroscience and Healthcare ETF to provide a consensus price target.
The stock price for iShares Neuroscience and Healthcare ETF (ARCA: IBRN) is $32.5183 last updated November 2, 2026 at 8:00 PM EST.
There are no upcoming dividends for iShares Neuroscience and Healthcare ETF.
iShares Neuroscience and Healthcare ETF does not have any upcoming earnings scheduled.
There is no upcoming split for iShares Neuroscience and Healthcare ETF.
The Fund seeks to track the investment results of the NYSE FactSet Global Neuro Biopharma and MedTech Index (the Underlying Index), which measures the performance of equity securities of companies that are involved in the research, development or...
